Latest News & Media
Feature Story
Dr. Justine Lee honored with Presidential Early Career Award
Dr. Justine Lee, Bernard G. Sarnat Professor of Craniofacial Biology and associate chief of plastic surgery at UCLA Health, received the prestigious Presidential Early Career Award for Scientists and Engineers (PECASE), the highest honor for early-career researchers. The award recognizes innovation and leadership in science and technology.
More Updates
Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds
A UCLA-led study suggests that chronic stress and an unhealthy diet accelerate pancreatic cancer development by activating cancer-promoting pathways. The researcj, co-led by Dr. Guido Eibl, professor in residence of surgery, and Dr. Joe Hines, professor and chair of surgery at UCLA, highlight beta-blockers as a potential preventive therapy.
Published in Molecular Cancer Research.
UCLA Liver Transplant Program uses 'revolutionary technology' to expand pool of usable organs
For patients with liver failure, the wait for a transplant can be long, and every moment counts. Dr. Douglas Farmer, chief of the Division of Liver and Pancreas Transplantation at UCLA Health, is transforming transplant care with ex vivo normothermic machine perfusion. This groundbreaking technology keeps livers warm and functional, expanding the donor pool and giving more patients a second chance at life.
UCLA vascular surgeon discusses Victor Wembanyama's deep vein thrombosis
Dr. Hugh A. Gelabert, professor of surgery in UCLA’s Division of Vascular and Endovascular Surgery, explained that Victor Wembanyama’s deep vein thrombosis (DVT) differs from Chris Bosh’s past condition. While Bosh’s DVT led to a pulmonary embolism, Wembanyama’s shoulder clot is typically lower risk.
Additional coverage: Sun Herald
Latest advances in cancer research and liver transplantation to be featured at Academic Surgical Congress
UCLA researchers will present over 70 abstracts at the 20th annual Academic Surgical Congress (ASC), highlighting cutting-edge advancements in breast lesion detection, robotic cancer resection, liver transplantation, and pancreatic cancer diagnostics.
Traveling to high-volume centers for esophageal cancer surgery improves survival
A study led by UCLA medical student Sara Sakowitz, MS, MPH, found that patients who traveled to high-volume centers for esophagectomy had significantly better 1-year and 5-year survival, especially those with stage III esophageal adenocarcinoma. The findings support centralizing complex oncologic care despite challenges like travel burden and continuity of care
Study reveals disparities in heart transplant outcomes among Medicaid patients
Dr. Peyman Benharash, cardiothoracic surgeon at UCLA Health, co-authored a UCLA-led study revealing that Medicaid-insured heart transplant patients face a higher risk of developing cardiac allograft vasculopathy (CAV), a condition that affects long-term survival. Published in The Annals of Thoracic Surgery, the study highlights how treatment at high-volume transplant centers can mitigate these risks, offering patients more consistent follow-up care and access to essential medications.
Additional coverage:
Cardiac surgery consortium improves outcomes and reduces costs
Dr. Richard J. Shemin, chief of cardiac surgery at UCLA Health, founded the University of California Cardiac Surgery Consortium (UCCSC) to enhance patient care across UC’s five health centers. By sharing data and best practices, the consortium has saved 132 bed days and improved financial margins by $15 million.
Multidisciplinary approach enhances peripheral artery disease (PAD) treatment
Dr. Vincent Rowe, chief of vascular and endovascular surgery at UCLA Health, leads a comprehensive team of specialists to treat complex PAD cases and prevent amputations. By integrating vascular and plastic surgery, wound care, podiatry, and hyperbaric medicine, UCLA Health has successfully preserved limbs and improved patient outcomes.